Pressmeddelande

BioStock Investor Pitch: DanCann Pharma

Cision Publicerad: 02 Nov 2022 08:59

Danish DanCann Pharma’s goal is to improve the lives of patients through medical cannabis and cannabinoids. The company has earlier this year signed an agreement with WEECO Pharma worth 40 million DKK and expects to reach its commercial breakthrough in the near future. In order to finance the next step in its development, the company is now carrying out a rights issue of 28.5 million DKK.

Watch the presentation at biostock.se:

https://www.biostock.se/en/2022/11/biostock-investor-pitch-dancann-pharma/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Nyheter om Dancann Pharma

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!